LYMPHOMA CONNECT has summarised highlights of the recent ASCO 2019 meeting
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.